MedPath

The Contact PVI Study: Use of Tissue Contact Data to Guide Atrial Fibrillation Ablation

Phase 4
Completed
Conditions
Atrial Fibrillation
Interventions
Procedure: ablation
Procedure: RF ablation
Registration Number
NCT01629056
Lead Sponsor
Oxford University Hospitals NHS Trust
Brief Summary

This study aims to investigate the benefit of a new impedance-based computer software application during routine catheter ablation for atrial fibrillation, to see if this information improves short and long term electrical disconnection of the pulmonary veins. This study will be a single blind prospective randomised control trial in patients undergoing AF ablation. Study participants will be randomly assigned to undergo parts of their pulmonary vein ablation with, and parts of their ablation without tissue contact data displayed for the doctor performing the ablation to see. The pulmonary veins will then be studied at the end of the procedure, and at any repeat procedure in the future, to look for a difference in the recovery rate of the ablations performed using contact data, compared to those ablations performed without the use of this contact data. If a reduction in tissue recovery is achieved through the use of this tissue contact data, it may lead in the future to a reduced need for repeat ablation procedures, and better outcomes for patients.

The investigators hypothesise that the use of the Ensite™ Contact™ ECI data will reduce the recovery of conduction, and promote long-term pulmonary vein isolation in patients undergoing left atrial ablation for atrial fibrillation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
148
Inclusion Criteria
  1. Participant is undergoing de novo pulmonary vein isolation procedure.
  2. Participant is willing and able to give informed consent for participation in the study.
  3. Male or Female, ≥18 years of age.
Exclusion Criteria
  1. Previous percutaneous or open surgical procedure involving the left atrium
  2. Pregnancy (current or currently planning)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Contact ECI activeablationContact ECI active
Contact information deactivatedRF ablationRF ablation without contact data
Primary Outcome Measures
NameTimeMethod
The primary outcome measure will be the proportion (%) of pulmonary vein pairs found to be reconnected electrically to the left atrium at a subsequent redo ablation procedure6 months
Secondary Outcome Measures
NameTimeMethod
touch-up ablation requirementsacute (intra-procedure)

proportion of veins requiring additional ablation after initial successful isolation, at the end of the index procedure

anatomical location of reconnections at repeat procedureat repeat ablation procerdure (6-12 months post index ablation procedure)

anatomical location of electrical reconnections in pulmonary vein antra, as measured at a repeat ablation procedure

complicationsacute and subacute (intra-procedure, and during entire follow-up period)

procedure-related complications

Proportion of acute venous electrical reconnectionsacute (intra-procedure)

proportion of pulmonary veins found to be electrically reconnected to the left atrium at the end of the index procedure

RF timeacute (intra-procedure)

total amount of radiofrequency ablation required

procedure timeacute

duration of procedure

amount of RF required to achieve re-isolation at repeat ablation procedureat repeat ablation procedure (6-12 months post-index ablation procedure)

total time of RF delivery required to re-isolate the reconnected pulmonary veins at a repeat ablation procedure

Trial Locations

Locations (1)

John Radcliffe Hospital

🇬🇧

Headington, Oxfordshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath